TrialScandinavian journal of gastroenterology2015

A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease.

Walter Reinisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.